MYCN and neuroblastoma: Additionally, compared with cisplatin, RTA-408 induced higher rates of both clonogenicity inhibition and apoptosis in MYCN-amplified neuroblastoma cells (Figure 6, D and E, and Supplemental Figure 9, A–C).